Welcome to Skilled in the Art. I’m Law.com IP reporter Scott Graham. Today is going to be life sciences day at SitA. I’ve got a few quick hits involving CRISPR gene editing patents, a battle between cancer treatment biopharmas, and the latest patent eligibility dispute in the medical diagnostics space. As always you can email me your own thoughts and follow me on Twitter.

Photo: Wikimedia Commons

CRISPR Battle Is Back on at the PTAB

Summer’s here, which means it’s sequel season. “Toy Story 4.” “Godzilla: King of the Monsters.” “CRISPR Interference II: Return to the PTAB.”